Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Rolland

Showing results (11-20 of 224) with videos related to

Pageof 23
Sort By:
Therapie|December 29, 2020
Pharmacotherapy of substance use disorders in the neuroscience-based nomenclature (NbN)Louise Carton, Mikaïl Nourredine, Benjamin Rolland
Alcohol and Alcoholism (Oxford, Oxfordshire)|May 9, 2020
Different Associations Between Alcohol Use Disorders and Psychotic Symptoms According to Underlying Psychiatric Disorders: The Need for Replication StudiesBaptiste Pignon, Guillaume Sescousse, Benjamin Rolland
Frontiers in Psychiatry|September 7, 2018
Safety Challenges of Using High Dose Baclofen for Alcohol Use Disorder: A Focused ReviewBenjamin Rolland, Nicolas Simon, Nicolas Franchitto
Frontiers in Psychiatry|October 24, 2018
Pharmacokinetic Studies of Baclofen Are Not Sufficient to Establish an Optimized Dosage for Management of Alcohol DisorderNicolas Simon, Nicolas Franchitto, Benjamin Rolland
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 20, 2018
The need for patient-tailored dosing of baclofen in future clinical trials<sup>☆</sup>Marie Costa, Benjamin Rolland, Patrizia Carrieri
Presse Medicale (Paris, France : 1983)|November 25, 2011
[Baclofen will also have to be compared with approved medications of alcohol dependence]Benjamin Rolland, Régis Bordet, Olivier Cottencin
Addiction (Abingdon, England)|February 14, 2012
Alcohol-dependence: the current French craze for baclofenBenjamin Rolland, Régis Bordet, Olivier Cottencin
The Journal of Emergency Medicine|January 30, 2014
Treatment of agitation in the emergency department: benzodiazepines could be safer than antipsychotics in some cases of insufficient medical dataBenjamin Rolland, Christophe Debien, Guillaume Vaiva
Expert Opinion on Drug Safety|March 19, 2016
Safety reports on the off-label use of baclofen for alcohol-dependence: recommendations to improve causality assessmentBenjamin Rolland, Marine Auffret, Nicolas Franchitto
Current Pharmaceutical Design|June 20, 2015
Methylphenidate in Adults with Attention Deficit Hyperactivity Disorder and Substance Use DisordersNicolas Simon, Benjamin Rolland, Laurent Karila
Pageof 23

Showing results (11-20 of 224) with videos related to

Sort By:
Pageof 23
Therapie|December 29, 2020
Pharmacotherapy of substance use disorders in the neuroscience-based nomenclature (NbN)Louise Carton, Mikaïl Nourredine, Benjamin Rolland
Alcohol and Alcoholism (Oxford, Oxfordshire)|May 9, 2020
Different Associations Between Alcohol Use Disorders and Psychotic Symptoms According to Underlying Psychiatric Disorders: The Need for Replication StudiesBaptiste Pignon, Guillaume Sescousse, Benjamin Rolland
Frontiers in Psychiatry|September 7, 2018
Safety Challenges of Using High Dose Baclofen for Alcohol Use Disorder: A Focused ReviewBenjamin Rolland, Nicolas Simon, Nicolas Franchitto
Frontiers in Psychiatry|October 24, 2018
Pharmacokinetic Studies of Baclofen Are Not Sufficient to Establish an Optimized Dosage for Management of Alcohol DisorderNicolas Simon, Nicolas Franchitto, Benjamin Rolland
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 20, 2018
The need for patient-tailored dosing of baclofen in future clinical trials<sup>☆</sup>Marie Costa, Benjamin Rolland, Patrizia Carrieri
Presse Medicale (Paris, France : 1983)|November 25, 2011
[Baclofen will also have to be compared with approved medications of alcohol dependence]Benjamin Rolland, Régis Bordet, Olivier Cottencin
Addiction (Abingdon, England)|February 14, 2012
Alcohol-dependence: the current French craze for baclofenBenjamin Rolland, Régis Bordet, Olivier Cottencin
The Journal of Emergency Medicine|January 30, 2014
Treatment of agitation in the emergency department: benzodiazepines could be safer than antipsychotics in some cases of insufficient medical dataBenjamin Rolland, Christophe Debien, Guillaume Vaiva
Expert Opinion on Drug Safety|March 19, 2016
Safety reports on the off-label use of baclofen for alcohol-dependence: recommendations to improve causality assessmentBenjamin Rolland, Marine Auffret, Nicolas Franchitto
Current Pharmaceutical Design|June 20, 2015
Methylphenidate in Adults with Attention Deficit Hyperactivity Disorder and Substance Use DisordersNicolas Simon, Benjamin Rolland, Laurent Karila
Pageof 23